首页 | 本学科首页   官方微博 | 高级检索  
     


Human recombinant interferonalpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study
Authors:Thompson Lori A  Grieshaber Terry L  Glickman Larry  Glickman Nita
Affiliation:Animal Allergy and Skin Disease Center, 6327 North Keystone Avenue, Indianapolis, IN, 46220, USA.
Abstract:The oral use of human recombinant interferonalpha-2b at 1,000 IU/ml/day appeared to provide only a transient benefit as compared with placebo for management of idiopathic recurrent superficial pyoderma in dogs. Further investigation using a larger population of dogs is needed to determine whether interferon is effective for long-term treatment of this condition.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号